home / stock / mrk / mrk articles

MRK Articles, Merck & Company Inc.

Stock Information
Company Name: Merck & Company Inc.
Stock Symbol: MRK
Market: NYSE
Website: merck.com
Menu
MRK MRK Quote MRK Short MRK News MRK Articles MRK Message Board
Get MRK Alerts

News, Short Squeeze, Breakout and More Instantly...
Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote | Benzinga

Merck (NYSE: MRK) announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP...
What's Going On With Merck Stock On Friday? | Benzinga

On Thursday, the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) unanimou...

Merck's Lung Cancer Candidate Faces FDA Rejection | Benzinga

Merck (NYSE: MRK) and its partner Daiichi Sankyo announced that the FDA has issued a complete response letter ("CRL") to the biologics li...

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug | Benzinga

On Wednesday, the FDA issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking accelerated approval of Daiichi S...
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth | Benzinga

Oppenheimer initiated coverage on Keros Therapeutics Inc (NASDAQ:KROS), a clinical-stage biopharmaceutical company that develops and commercializes...

Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says | Benzinga

Oppenheimer initiated coverage on Gossamer Bio Inc (NASDAQ:GOSS), a clinical-stage biopharmaceutical company, with an Outperform rating and a price...

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More | Benzinga

Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary event...
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments | Benzinga

Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. B...

Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry | Benzinga

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and...

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment | Benzinga

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its ...
Next 10